Terms: = Liver cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716 AND Prognosis
13 results:
1. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via jak1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract] [Full Text] [Related]
2. TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma.
Sakamoto T; Kuboki S; Furukawa K; Takayashiki T; Takano S; Yoshizumi A; Ohtsuka M
Liver Int; 2023 Jan; 43(1):194-207. PubMed ID: 35753056
[TBL] [Abstract] [Full Text] [Related]
3. Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p/RNF125/jak1 axis.
Peng R; Cao J; Su BB; Bai XS; Jin X; Wang AQ; Wang Q; Liu RJ; Jiang GQ; Jin SJ; Zhang C; Bai DS
Cancer Lett; 2022 Sep; 543():215778. PubMed ID: 35710093
[TBL] [Abstract] [Full Text] [Related]
4. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract] [Full Text] [Related]
5. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
[TBL] [Abstract] [Full Text] [Related]
6. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of jak1/STAT3 and AKT signaling.
Wang H; Hou W; Perera A; Bettler C; Beach JR; Ding X; Li J; Denning MF; Dhanarajan A; Cotler SJ; Joyce C; Yin J; Ahmed F; Roberts LR; Qiu W
Cell Rep; 2021 Feb; 34(8):108765. PubMed ID: 33626345
[TBL] [Abstract] [Full Text] [Related]
7. The inhibition of IL-2/IL-2R gives rise to CD8
Shi H; Wang W; Yin J; Ouyang Y; Pang L; Feng Y; Qiao L; Guo X; Shi H; Jin R; Chen D
Cell Death Dis; 2020 Jun; 11(6):429. PubMed ID: 32513989
[TBL] [Abstract] [Full Text] [Related]
8. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
9. [Severe MDA5 dermatomyositis associated with cancer and controlled by JAK inhibitor].
Jalles C; Deroux A; Tardieu M; Lugosi M; Viel S; Benveniste O; Colombe B
Rev Med Interne; 2020 Jun; 41(6):421-424. PubMed ID: 32192753
[TBL] [Abstract] [Full Text] [Related]
10. A novel HBx genotype serves as a preoperative predictor and fails to activate the jak1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract] [Full Text] [Related]
11. Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic cancer for Whom Therapy With Gemcitabine Has Failed.
Hurwitz HI; Uppal N; Wagner SA; Bendell JC; Beck JT; Wade SM; Nemunaitis JJ; Stella PJ; Pipas JM; Wainberg ZA; Manges R; Garrett WM; Hunter DS; Clark J; Leopold L; Sandor V; Levy RS
J Clin Oncol; 2015 Dec; 33(34):4039-47. PubMed ID: 26351344
[TBL] [Abstract] [Full Text] [Related]
12. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
[TBL] [Abstract] [Full Text] [Related]
13. [Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].
Zhang B; Zhong DW; Wang QW; Miao XY; Dai WD; Liu C; Pan KH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):368-70, 373. PubMed ID: 20368117
[TBL] [Abstract] [Full Text] [Related]
